Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australian Senate panel does not ban gene patenting; new bill may prohibit practice

This article was originally published in RAJ Devices

Executive Summary

The Australian Senate committee that is looking into the impact of gene patents on healthcare and medical research has stopped short of recommending an express prohibition on the patenting of genes1,2. It has instead suggested numerous reforms to improve the quality of patents and the operation of the patent system in general, to ensure that a patent is granted only where an invention is "sufficiently novel, inventive and useful".

Latest Headlines
See All
UsernamePublicRestriction

Register

SC096423

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel